Cisco
CSCO
NVIDIA
NVDA
Taiwan Semiconductor
TSM
4
ASML Holding
ASML
5
Broadcom
AVGO
US Stock MarketDetailed Quotes
PLRZ Polyrizon
- 0.470
- -0.029-5.74%
Trading Mar 28 15:18 ET
2.07MMarket Cap1.23P/E (TTM)
0.520High0.453Low198.59KVolume0.507Open0.499Pre Close95.45KTurnover24.59%Turnover Ratio1.23P/E (Static)4.39MShares4.80052wk High0.39P/B379.62KFloat Cap0.45352wk Low--Dividend TTM807.69KShs Float4.800Historical High--Div YieldTTM13.34%Amplitude0.453Historical Low0.480Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Polyrizon Stock Forum
Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting
Thursday, 27th March at 8:25 am
Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward
Raanana, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced the structuring of its clinical strategy for PL-14,...
3 min candles look beautiful.
Revolutionary Nasal Spray Could Transform Emergency Epilepsy Treatment, Polyrizon Reveals New Data
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
Polyrizon Expands Drug Delivery Innovation With Preclinical Studies for Epilepsy Rescue Treatment
Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment
Tuesday, 25th March at 4:04 pm
Raanana, Israel, March 25, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of preclinical studies for intranasal Benzodiazepines (BZDs), a first-line treatment for acute re...
No comment yet